Ventura T, Lobo A, Marco J C
Colegio Universitario de Soria.
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1990 Sep-Oct;18(5):339-43.
The presence of H.L.A. antigens in bipolar affective patients attending in the University Hospital of Zaragoza was studied and contrasted with findings in the general population. A random sample of 36 patients was selected for the study. All of them fulfill, both, DSM-III and RDC diagnostic criteria . The HLA antigen was studied by means of Lymphotoxicity Test of N.I.H. standard technique. Both, A29 and B21 HLA antigens were detect in the bipolar patients more frequently that in the controls (Histocompatibility Testing data, 1980), and the differences were statistically significant. It is also suggested that the A2 HLA antigen is more frequently found in bipolar patients "non-respondent" to lithium treatment. The inclination to relate these antigens to specifics genes in the bipolar illness should be pondered, since the risk of "false positives" inherent in studies testing association hypothesis is well known.
对萨拉戈萨大学医院双相情感障碍患者体内H.L.A.抗原的存在情况进行了研究,并与普通人群的研究结果进行了对比。研究选取了36名患者的随机样本。他们均符合《精神疾病诊断与统计手册》第三版(DSM-III)和研究诊断标准(RDC)。采用美国国立卫生研究院(N.I.H.)标准技术的淋巴细胞毒性试验来研究HLA抗原。在双相情感障碍患者中检测到A29和B21这两种HLA抗原的频率高于对照组(组织相容性检测数据,1980年),且差异具有统计学意义。研究还表明,在对锂治疗“无反应”的双相情感障碍患者中,A2 HLA抗原的出现频率更高。鉴于检验关联假设的研究中存在众所周知的“假阳性”风险,对于将这些抗原与双相情感障碍中的特定基因相关联的倾向应予以慎重考虑。